SEC Form 4 reporting owner

MPM BioVentures 2014, L.P.

MPM BioVentures 2014, L.P. has filed 15 Form 4 transactions reported between December 2, 2025 and September 9, 2026, as a reporting owner of Entrada Therapeutics, Inc. and a reporting owner of Werewolf Therapeutics, Inc..

Name as filed: MPM BioVentures 2014, L.P.

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$3.8M
15 lines
Companies
2
with Form 4 filings
Latest transaction
Sep 9, 2026
transaction date

Roles and reported holdings

  • TRDAEntrada Therapeutics, Inc.
    Aug 24, 2026 – Sep 9, 2026

    Reporting owner

    Held indirectly (latest line)3,885,115 sh as of Sep 9, 2026 · Form 4

    24 months: $3.6M sold

  • HOWLWerewolf Therapeutics, Inc.
    Dec 2, 2025 – Dec 4, 2025

    Reporting owner

    Held indirectly (latest line)4,784,111 sh as of Dec 4, 2025 · Form 4

    24 months: $183K sold

Transaction history

All 15 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Sep 9, 2026TRDAOpen-market saleCode S · indirectAlso reported by MPM BIOVENTURES 2018, L.P.28,837$206K@ $7.13Form 4
Sep 8, 2026TRDAOpen-market saleCode S · indirectAlso reported by MPM BIOVENTURES 2018, L.P.192,500$1.4M@ $7.41Form 4
Sep 4, 2026TRDAOpen-market saleCode S · indirectAlso reported by MPM BIOVENTURES 2018, L.P.38,500$274K@ $7.11Form 4
Sep 3, 2026TRDAOpen-market saleCode S · indirectAlso reported by MPM BIOVENTURES 2018, L.P.32,263$231K@ $7.17Form 4
Sep 2, 2026TRDAOpen-market saleCode S · indirectAlso reported by MPM BIOVENTURES 2018, L.P.25,131$181K@ $7.19Form 4
Sep 1, 2026TRDAOpen-market saleCode S · indirectAlso reported by MPM BIOVENTURES 2018, L.P.29,088$205K@ $7.06Form 4
Aug 31, 2026TRDAOpen-market saleCode S · indirectAlso reported by MPM BIOVENTURES 2018, L.P.44,259$309K@ $6.99Form 4
Aug 28, 2026TRDAOpen-market saleCode S · indirectAlso reported by MPM BIOVENTURES 2018, L.P.3,733$26K@ $7.01Form 4
Aug 27, 2026TRDAOpen-market saleCode S · indirectAlso reported by MPM BIOVENTURES 2018, L.P.38,922$280K@ $7.20Form 4
Aug 26, 2026TRDAOpen-market saleCode S · indirectAlso reported by MPM BIOVENTURES 2018, L.P.14,569$103K@ $7.06Form 4
Aug 25, 2026TRDAOpen-market saleCode S · indirectAlso reported by MPM BIOVENTURES 2018, L.P.26,522$200K@ $7.54Form 4
Aug 24, 2026TRDAOpen-market saleCode S · indirectAlso reported by MPM BIOVENTURES 2018, L.P.21,623$159K@ $7.34Form 4
Dec 4, 2025HOWLOpen-market saleCode S · indirectAlso reported by GADICKE ANSBERT83,230$81K@ $0.9700Form 4
Dec 3, 2025HOWLOpen-market saleCode S · indirectAlso reported by GADICKE ANSBERT57,225$50K@ $0.8700Form 4
Dec 2, 2025HOWLOpen-market saleCode S · indirectAlso reported by GADICKE ANSBERT59,277$53K@ $0.8900Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.